methylphenidate has been researched along with Delirium of Mixed Origin in 13 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the clinical improvement observed in patients with advanced cancer and hypoactive delirium after the administration of methylphenidate hydrochloride." | 9.11 | Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study. ( Gagnon, B; Low, G; Schreier, G, 2005) |
| "Delirium is frequently observed in terminally ill cancer patients, but complete remission is often difficult to achieve." | 5.31 | Successful palliation of hypoactive delirium due to multi-organ failure by oral methylphenidate. ( Chihara, S; Inoue, S; Morita, T; Otani, H; Tsunoda, J, 2000) |
| "To investigate the clinical improvement observed in patients with advanced cancer and hypoactive delirium after the administration of methylphenidate hydrochloride." | 5.11 | Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study. ( Gagnon, B; Low, G; Schreier, G, 2005) |
| "The reviewed studies support the use of methylphenidate to improve end-of-life patient cognitive functions, particularly in the case of hypoactive delirium." | 4.86 | [Using psychostimulants in end-of-life patients with hypoactive delirium and cognitive disorders: A literature review]. ( Elie, D; Gagnon, B; Gagnon, P; Giguère, A, 2010) |
| "Methylphenidate provides a safe and effective alternative to tricyclic antidepressants in medically ill populations but appears to be less effective in the presence of delirium." | 3.68 | Methylphenidate in depressed medically ill patients. ( Ahmed, I; Hurwitz, S; Rosenberg, PB, 1991) |
| "Delirium has been well defined and reported as a significant problem in populations of patients receiving palliative care." | 1.32 | Psychostimulants and delirium in patients receiving palliative care. ( Brown, D; Keen, JC, 2004) |
| "Delirium is frequently observed in terminally ill cancer patients, but complete remission is often difficult to achieve." | 1.31 | Successful palliation of hypoactive delirium due to multi-organ failure by oral methylphenidate. ( Chihara, S; Inoue, S; Morita, T; Otani, H; Tsunoda, J, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vérité, F | 1 |
| Micallef, J | 1 |
| Elie, D | 1 |
| Gagnon, P | 1 |
| Gagnon, B | 2 |
| Giguère, A | 1 |
| Meyers, BJ | 1 |
| van Ojen, RL | 1 |
| Rikkert, MG | 1 |
| Geurts, AC | 1 |
| Lem, FC | 1 |
| Low, G | 1 |
| Schreier, G | 1 |
| Keen, JC | 1 |
| Brown, D | 1 |
| Hales, RE | 1 |
| Hershey, SC | 1 |
| Morita, T | 1 |
| Otani, H | 1 |
| Tsunoda, J | 1 |
| Inoue, S | 1 |
| Chihara, S | 1 |
| Levenson, JA | 1 |
| Rosenberg, PB | 1 |
| Ahmed, I | 1 |
| Hurwitz, S | 1 |
| Ketchum, JS | 1 |
| Sidell, FR | 1 |
| Crowell, EB | 1 |
| Aghajanian, GK | 1 |
| Hayes, AH | 1 |
| Malkin, M | 1 |
| Hirsch, AC | 1 |
2 reviews available for methylphenidate and Delirium of Mixed Origin
| Article | Year |
|---|---|
[Using psychostimulants in end-of-life patients with hypoactive delirium and cognitive disorders: A literature review].
Topics: Aged; Caffeine; Central Nervous System Stimulants; Cognition Disorders; Confusion; Delirium; Depress | 2010 |
Psychopharmacologic issues in the diagnosis and treatment of organic mental disorders.
Topics: Adrenal Cortex Hormones; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Delirium; Dementia; | 1984 |
1 trial available for methylphenidate and Delirium of Mixed Origin
| Article | Year |
|---|---|
Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study.
Topics: Adolescent; Aged; Aged, 80 and over; Central Nervous System Stimulants; Cognition; Delirium; Female; | 2005 |
10 other studies available for methylphenidate and Delirium of Mixed Origin
| Article | Year |
|---|---|
[Acute psychiatric symptoms during methylphenidate intravenous injections: A case report].
Topics: Adult; Akathisia, Drug-Induced; Central Nervous System Stimulants; Delirium; Humans; Injections, Int | 2017 |
[The treatment with methylphenidate of demoralisation, apathy and hypoactive delirium in patients with somatic illness].
Topics: Adult; Aged; Central Nervous System Stimulants; Delirium; Depression; Female; Humans; Lymphoma, B-Ce | 2004 |
[The treatment with methylphenidate of demoralisation, apathy and hypoactive delirium in patients with somatic illness].
Topics: Central Nervous System Stimulants; Clinical Trials as Topic; Delirium; Depression; Diagnosis, Differ | 2004 |
[The treatment with methylphenidate of demoralisation, apathy and hypoactive delirium in patients with somatic illness].
Topics: Central Nervous System Stimulants; Delirium; Depression; Humans; Methylphenidate; Somatoform Disorde | 2004 |
Psychostimulants and delirium in patients receiving palliative care.
Topics: Aged; Central Nervous System Stimulants; Delirium; Fatal Outcome; Female; Humans; Kidney Neoplasms; | 2004 |
Successful palliation of hypoactive delirium due to multi-organ failure by oral methylphenidate.
Topics: Central Nervous System Stimulants; Delirium; Female; Humans; Methylphenidate; Middle Aged; Multiple | 2000 |
Should psychostimulants be used to treat delirious patients with depressed mood?
Topics: Delirium; Depression; Depressive Disorder; Humans; Methylphenidate | 1992 |
Methylphenidate in depressed medically ill patients.
Topics: Adjustment Disorders; Adult; Aged; Aged, 80 and over; Cerebrovascular Disorders; Clinical Trials as | 1991 |
Atropine, scopolamine, and ditran: comparative pharmacology and antagonists in man.
Topics: Acridines; Adult; Atropine; Behavior; Blood Pressure; Central Nervous System; Delirium; Glycolates; | 1973 |
Postanesthetic delirium and its treatment. Preliminary report.
Topics: Adult; Anesthesia, General; Barbiturates; Child; Child, Preschool; Delirium; Female; Humans; Hydroxy | 1966 |